These products enable brand owners to meet regulatory requirements and increase patient safety.
Essentra provides item-level serialisation from externally supplied data, which negates the need for customers to set up and manage print in-house. This can be provided via printed labels and through the company’s range of carton options, which includes ready-to-pack serialised cartons.
For further enhanced security, tamper verification can be added by sealing access points either via glue or using labels such as fibre-tear, void-release or frangible.
Essentra’s tamper verification glued carton allows customers to glue the carton at the point of product packaging. Irreversible tamper verification is created when the carton is opened either through tearing it or opening via more consumer-friendly design perforations.
There are three new tamper verification labels as part of Essentra’s new portfolio:
- Fibre-tear labels – irreversibly damages both print and carton board on to which it is affixed (including varnished coatings)
- Void-release labels – leaves a void message or pattern behind when the label is removed
- Frangible film labels – uses a specially engineered substrate that disintegrates the label when attempting to remove from the carton board
Ian Lemon, global product director, health and personal care packaging, said: “It is imperative that pharmaceutical companies are prepared to deal with the threat posed by counterfeiters, not only from a compliance perspective as a result of legislation, but also to protect their brand identity and do their part to help ensure patients are consuming the genuine medicine they require.
“Essentra advocates multiple levels of solutions, including track and trace serialisation and tamper evident solutions. This new range of products demonstrates our commitment to innovation and to meeting the needs of our customers in an increasingly challenging marketplace.”
Source: Packaging News | Jobs | Production | Design | Innovation » News